SEC Form 4 · accession 0001104659-17-032408
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur S Kirsch
Director
Period of report
May 11, 2017
Accepted (ET)
May 12, 2017 · 9:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par valueF2 | May 11, 2017 | A | 7,500 | $0.00 | A | 156,609 | D | |
| Common Shares, without par valueF3 | holding | — | — | — | 5,000 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F4 | $1.56 | May 11, 2017 | A | 15,000 | A | — | May 11, 2027 | Common Stock, without par value | 15,000 | 15,000 | D |
Explanation of responses
- F1Restricted Stock Units, all of which vest on May 11, 2018, subject to the director's continued service on the Board as of such date.
- F2Includes 149,109 shares of Common Stock and 7,500 Restricted Stock Units.
- F3The shares are held by the Laura A. Kirsch Trust, dated 4/12/2000 (the "Trust"), of which the Reporting Person is a trustee. Pursuant to General Instruction 4(b)(iv) to Form 4, all of the Issuer's securities held by the Trust are reported herein, and the Reporting Person expressly disclaims beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein.
- F4The option vests in one installment on May 11, 2018, subject to the director's continued service on the Board as of such date.